Biosource International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mike mulhearn who wrote (72)	3/10/1997 2:15:00 PM
From: Ted Gregg	of 696

Wedbush Morgan Rates Biosource Intl Initial Buy NEW YORK (Dow Jones)--Wedbush Morgan Securities started coverage of Biosource International Inc. (BIOI) with a buy rating. In a research note, Wedbush said the company is positioned to benefit from the growing number of new biotech companies and the changing structure of large pharmaceutical companies. The brokerage firm estimates 1997 net income of 47 cents a share. "Dow Jones News Service" "Copyright(c) 1997, Dow Jones & Company, Inc." This should help us long BIOI! Ted

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next